Cochlear (CHEOF) Stock Price, News & Analysis

Company Overview

Cochlear Limited is an Australia-based medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may receive limited benefit from conventional hearing aids.

The company’s portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products. Cochlear also provides clinical support, rehabilitation resources, software and ongoing services for recipients, hearing professionals and healthcare providers.

Cochlear traces its origins to research led by Australian ear scientist Graeme Clark, whose work contributed to the development of the modern multichannel cochlear implant. The company was established in the 1980s and serves patients and healthcare markets internationally, with products and services available across North America, Europe, Asia-Pacific and other regions.

Key Stats

• Today's Range: $93.61 to $93.61
• 50-Day Range: $78.95 to $101.05
• 52-Week Range: $64.39 to $202.61
• Volume: N/A
• Average Volume: 1,416 shs
• Market Capitalization: N/A
• P/E Ratio: 57.01
• Dividend Yield: 1.36%
• Price Target: N/A
• Consensus Rating: N/A

Cochlear Stock Analysis - MarketRank™

Cochlear scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cochlear.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cochlear is 57.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.53.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cochlear is 57.01, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.76.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cochlear has a short interest ratio ("days to cover") of 792.26, which indicates bearish sentiment.

Change versus previous month

Short interest in Cochlear has recently decreased by 4.86%, indicating that investor sentiment is improving.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Cochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cochlear does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Cochlear this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cochlear insiders have not sold or bought any company stock.

Percentage Held by Institutions

22.47% of the stock of Cochlear is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CHEOF
• CIK: 1453930
• Web: www.cochlear.com
• Phone: (129) 428-6555
• Fax: N/A
• Employees: 4,800
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 57.01
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A